PVRI International Conference 2025: Embracing Heterogeneity

QR Code

PVRI International Conference 2025: Embracing Heterogeneity

Saved in:

Bibliographic Details
Main Authors:	Navneet Singh, Katarina Zeder
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	Pulmonary Circulation
Subjects:	conference pulmonary hypertension pulmonary vascular research institute
Online Access:	https://doi.org/10.1002/pul2.70093
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries
by: Armella Santi, et al.
Published: (2025-04-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)

Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease
by: Raj Parikh, et al.
Published: (2025-07-01)

Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients
by: Elva Mendoza-Zambrano, et al.
Published: (2025-06-01)

Porto-Pulmonary Hypertension and Hepato-Pulmonary Syndrome: Diagnostic Procedures and Therapeutic Management
by: Roberto G. Carbone, et al.
Published: (2025-07-01)

Baseline pulmonary hypertension in heart transplant recipients: 9 years of experience at Almazov National Medical Research Centre
by: M. A. Simonenko, et al.
Published: (2020-02-01)

Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow‐up of 86 patients
by: Gabriel F. Diaz, et al.
Published: (2025-04-01)

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Anggoro Budi Hartopo, et al.
Published: (2017-08-01)

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Anggoro Budi Hartopo, et al.
Published: (2017-08-01)

Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post‐ and Precapillary Pulmonary Hypertension: A Propensity Score‐Matched Analysis From the Hellenic Pulmonary Hypertension Registry
by: Georgios E. Papadopoulos, et al.
Published: (2025-04-01)

Semi-Automated Graphical System for Calculating Pulmonary Vascular Impedances in a Clinical Setting
by: Timothy Bachman, et al.
Published: (2021-01-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

THE EFFICIENCY OF BOSENTAN BASED ON THE DATA OF THE REGISTER OF PATIENTS WITH PULMONARY HYPERTENSION IN THE VORONEZH REGION
by: O. M. Korolkova
Published: (2017-06-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
by: O. M. Korolkova, et al.
Published: (2019-06-01)

Comparative Histopathological Evaluation of Pulmonary Arterial Remodeling in Fatal COVID-19 and H1N1 Influenza Autopsy Cases
by: Sergiy G. Gychka, et al.
Published: (2025-05-01)

DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE
by: E. A. Zhuk, et al.
Published: (2012-06-01)

Evaluation of radiographic pulmonary artery diameter and echocardiographic pulmonary artery pressure in COPD patients in South-West Nigeria
by: Zuliat A. Awoyemi, et al.
Published: (2025-07-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)
by: I. E. Chazova, et al.
Published: (2021-03-01)

Ginsenoside Rg1 Ameliorates Pulmonary Hypertension by Inhibiting cGAS/STING Mediated Cell Senescence
by: Ding R, et al.
Published: (2025-07-01)

Statistical modeling to determine severity of respiratory sarcoidosis and parameters associated with cardiac sarcoidosis: as a way to stratify the risk of developing pulmonary hypertension
by: T. P. Kalacheva, et al.
Published: (2025-04-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data
by: M. A. Simakova, et al.
Published: (2020-05-01)

Long-Term Results of Surgical Treatment of Pulmonary Embolism (PE) by Balloon Angioplasty (BAP) in Combination with Thrombolytic Therapy
by: M. V. Davydenko, et al.
Published: (2019-01-01)

"Suffocating from the unknown". Case report
by: A. G. Saribekyan, et al.
Published: (2023-06-01)

Pulmonary artery denervation in patients with pulmonary hypertension: present state and clinical experience
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

SURGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: MODERN TRENDS AND OWN EXPERIENCE
by: R. S. Akchurin, et al.
Published: (2016-06-01)

A clinical case of radiofrequency pulmonary artery denervation for treatment of a patient with residual chronic thromboembolic pulmonary hypertension
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

Real-world experiences and treatment patterns among congenital heart disease patients with associated pulmonary vascular disease: Results from a real-world survey in the United States
by: Jordan D. Awerbach, MD, MPH, et al.
Published: (2025-08-01)

Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides
by: Priya Murugesan, et al.
Published: (2025-09-01)

Effects of pulmonary endarterectomy and balloon pulmonary angioplasty in older adults with chronic thromboembolic pulmonary hypertension: A sub-analysis of the CTEPH AC registry
by: Jun Yamashita, et al.
Published: (2025-10-01)

ENDOVASCULAR TREATMENT OF THE RESIDUAL THROMBOEMBOLIC PULMONARY HYPERTENSION AFTER PULMONARY THROMBENDARTERECTOMY WITH THE DENERVATION SYSTEM SYMPLICITY
by: B. A. Rudenko, et al.
Published: (2018-04-01)

Pathomorphological changes in pulmonary vessels at different terms of lethal outcomes of patients with COVID-19
by: S. S. Todorov, et al.
Published: (2021-07-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

PULMONARY HYPERTENSION IN PEDIATRIC PRACTICE
by: V. E. Tril, et al.
Published: (2018-12-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

PULMONARY ARTERIAL HYPERTENSION: REGIONAL HEALTH CARE OPPORTUNITIES
by: E. V. Filippov
Published: (2021-05-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
by: I. E. Chazova, et al.
Published: (2024-03-01)

Russian consensus: balloon pulmonary angioplasty in treatment of chronic thromboembolic pulmonary hypertension
by: N. M. Danilov, et al.
Published: (2025-03-01)